Trial intelligence / Profile preview

Articaine vs Lidocaine for Irreversible Pulpitis

NCT01912755Phase 4Completed

Sponsor
Universidade Estadual de Campinas
Start
Feb 2010
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of articaine in irreversible pulpitis, sponsored by Universidade Estadual de Campinas. Started Feb 2010; status: completed.

02

Drugs

articaine
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT01912755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01912755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call